Sponsor

King's College London

United Kingdom Strand, WC2R 2LS, United Kingdom

About the sponsor

King's College London is involved in clinical research focused on exudative age-related macular degeneration, with particular attention to complications affecting the central retina and visual function.

Wet age-related macular degeneration
Submacular haemorrhage
Macular pathology

The sponsor's activity in this area reflects interest in conditions that threaten central vision and require specialised ophthalmic care.

About Specializations

King's College London runs clinical trials in conditions such as Neovascular age-related macular degeneration, among others.

Neovascular age-related macular degeneration

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

1 clinical trial

Neovascular age-related macular degeneration

Recruiting

Registered drugNo placebo

Study on Vitrectomy, Alteplase, and Aflibercept for Patients with Wet Age-Related Macular Degeneration and Submacular Hemorrhage

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Aflibercept
Sponsor:King's College Hospital NHS Foundation Trust

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →